Generic Product News: March 2023
Products include a new NSAID and an oral solution for depression.
Stay updated with breaking news from Extended Release Capsules. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Products include a new NSAID and an oral solution for depression.
Products include oral suspension for gout and tablets that prevent low carnitine levels in the blood.
Zydus Lifesciences Ltd's subsidiary Zydus Pharmaceuticals USA Inc. has received tentative approval from the USFDA to market Levomilnacipran Extended-Release Capsules, 20 mg, 40 mg, 80 mg, and 120 mg
Potassium Chloride Oral Solution is indicated for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis, in patients for whom dietary management with potassium rich foods or...
The Company also has a pipeline of other Potassium Chloride products which are expected to be approved and launched in FY24.